Search

Your search keyword '"Tranvouez, J"' showing total 16 results
Start Over Author "Tranvouez, J"
16 results on '"Tranvouez, J"'

1. A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based Study

Author

Sarter, Hélène, Savoye, Guillaume, Marot, Guillemette, Ley, Delphine, Turck, Dominique, Hugot, Jean-Pierre, Vasseur, Francis, Duhamel, Alain, Wils, Pauline, Princen, Fred, Colombel, Jean-Frédéric, Gower-Rousseau, Corinne, Fumery, Mathurin, Al Hameedi, R, Al Khatib, M, Al Turk, S, Agoute, E, Andre, J, Antonietti, M, Aouakli, A, Armand, A, Armengol-Debeir, L, Aroichane, I, Assi, F, Aubet, J, Auxenfants, E, Avram, A, Ayafi-Ramelot, F, Azzouzi, K, Bankovski, D, Barbry, B, Bardoux, N, Baron, P, Baudet, A, Bayart, P, Bazin, B, Bebahani, A, Becqwort, J, Bellati, S, Benet, V, Benali, H, Benard, C, Benguigui, C, Ben Soussan, E, Bental, A, Berkelmans, I, Bernet, J, Bernou, K, Bernou-Dron, C, Bertot, P, Bertiaux-Vandaële, N, Bertrand, V, Billoud, E, Biron, N, Bismuth, B, Bleuet, M, Blondel, F, Blondin, V, Bobula, M, Bohon, P, Bondjemah, V, Boniface, E, Bonkovski, D, Bonnière, P, Bonvarlet, E, Bonvarlet, P, Boruchowicz, A, Bostvironnois, R, Boualit, M, Bouazza, A, Bouche, B, Boudaillez, C, Bourgeaux, C, Bourgeois, M, Bourguet, A, Bourienne, A, Boutaleb, H, Bouthors, A, Branche, J, Bray, G, Brazier, F, Breban, P, Bridenne, M, Brihier, H, Bril, L, Brung-Lefebvre, V, Bulois, P, Burgiere, P, Butel, J, Canva, J, Canva-Delcambre, V, Capron, J, Cardot, F, Carette, S, Carpentier, P, Cartier, E, Cassar, J, Cassagnou, M, Castex, J, Catala, P, Cattan, S, Catteau, S, Caujolle, B, Cayron, G, Chandelier, C, Chantre, M, Charles, J, Charneau, T, Chavance-Thelu, M, Cheny, A, Chirita, D, Choteau, A, Claerbout, J, Clergue, P, Coevoet, H, Cohen, G, Collet, R, Colin, M, Colombel, J, Coopman, S, Cordiez, L, Corvisart, J, Cortot, A, Couttenier, F, Crinquette, J, Crombe, V, Dadamessi, I, Daoudi, H, Dapvril, V, Davion, T, Dautreme, S, Debas, J, Decoster, S, Degrave, N, Dehont, F, Delatre, C, Delcenserie, R, Delesalle, D, Delette, O, Delgrange, T, Delhoustal, L, Delmotte, J, Demmane, S, Deregnaucourt, G, Descombes, P, Desechalliers, J, Desmet, P, Desreumaux, P, Desseaux, G, Desurmont, P, Devienne, A, Devouge, E, Devred, M, Devroux, A, Dewailly, A, Dharancy, S, Di Fiore, A, Djedir, D, Djedir, R, Doleh, W, Dreher-Duwat, M, Dubois, R, Duburque, C, Ducatillon, P, Duclay, J, Ducrocq, B, Ducrot, F, Ducrotte, P, Dufilho, A, Duhamel, C, Dujardin, D, Dumant-Forest, C, Dupas, J, Dupont, F, Duranton, Y, Duriez, A, Duveau, N, El Achkar, K, El Farisi, M, Elie, C, Elie-Legrand, M, Elkhaki, A, Eoche, M, Essmaeel, E, Evrard, D, Evrard, J, Fatome, A, Filoche, B, Finet, L, Flahaut, M, Flamme, C, Foissey, D, Fournier, P, Foutrein-Comes, M, Foutrein, P, Fremond, D, Frere, T, Gallais, P, Gamblin, C, Ganga, S, Gerard, R, Geslin, G, Gheyssens, Y, Ghossini, N, Ghrib, S, Gilbert, T, Gillet, B, Godart, D, Godard, P, Godchaux, J, Godchaux, R, Goegebeur, G, Goria, O, Gottrand, F, Gower, P, Grandmaison, B, Groux, M, Guedon, C, Guerbeau, L, Gueroult-Dero, M, Guillard, J, Guillem, L, Guillemot, F, Guimberd, D, Haddouche, B, Hakim, S, Hanon, D, Hautefeuille, V, Heckestweiller, P, Hecquet, G, Hedde, J, Hellal, H, Henneresse, P, Heyman, B, Heraud, M, Herve, S, Hochain, P, Houssin-Bailly, L, Houcke, P, Huguenin, B, Iobagiu, S, Istanboli, S, Ivanovic, A, Iwanicki-Caron, I, Janicki, E, Jarry, M, Jeu, J, Joly, J, Jonas, C, Jouvenet, A, Katherin, F, Kerleveo, A, Khachfe, A, Kiriakos, A, Kiriakos, J, Klein, O, Kohut, M, Kornhauser, R, Koutsomanis, D, Laberenne, J, Lacotte, E, Laffineur, G, Lagarde, M, Lalanne, A, Lalieu, A, Lannoy, P, Lapchin, J, Laprand, M, Laude, D, Leblanc, R, Lecieux, P, Lecleire, S, Leclerc, N, Le Couteulx, C, Ledent, J, Lefebvre, J, Lefiliatre, P, Le Goffic, C, Legrand, C, Le Grix, A, Lelong, P, Leluyer, B, Lemaitre, C, Lenaerts, C, Lepeut, G, Lepileur, L, Leplat, A, Lepoutre-Dujardin, E, Leroi, H, Leroy, M, Le Roy, P, Lesage, B, Lesage, J, Lesage, X, Lescanne-Darchis, I, Lescut, J, Lescut, D, Leurent, B, Levy, P, Lhermie, M, Libier, L, Lion, A, Lisambert, B, Loge, I, Loire, F, Loreau, J, Louf, S, Louvet, A, Lubret, L, Luciani, M, Lucidarme, D, Lugand, J, Macaigne, O, Maetz, D, Maillard, D, Mancheron, H, Manolache, O, Marks-Brunel, A, Marre, C, Marti, R, Martin, F, Martin, G, Marzloff, E, Mathurin, P, Mauillon, J, Maunoury, V, Maupas, J, Medam Djomo, M, Mechior, C, Melki, Z, Mesnard, B, Metayer, P, Methari, L, Meurisse, B, Meurisse, F, Michaud, L, Mirmaran, X, Modaine, P, Monthe, A, Morel, L, Mortier, P, Moulin, E, Mouterde, O, Mozziconaci, N, Mudry, J, Nachury, M, Ngo, M, N’guyen Khac, Eric, Notteghem, B, Ollevier, V, Ostyn, A, Ouraghi, A, Oussadou, B, Ouvry, D, Paillot, B, Painchart, C, Panien-Claudot, N, Paoletti, C, Papazian, A, Parent, B, Pariente, B, Paris, J, Patrier, P, Paupard, T, Pauwels, B, Pauwels, M, Penninck, E, Petit, R, Piat, M, Piotte, S, Plane, C, Plouvier, B, Pollet, E, Pommelet, P, Pop, D, Pordes, C, Pouchain, G, Prades, P, Prevost, A, Prevost, J, Quartier, G, Quesnel, B, Queuniet, A, Quinton, J, Rabache, A, Rabelle, P, Raclot, G, Ratajczyk, S, Rault, D, Razemon, V, Reix, N, Renaut-Vantroys, T, Revillion, M, Riachi, G, Richez, C, Robinson, P, Rodriguez, J, Roger, J, Roux, J, Rudelli, A, Saber, A, Savoye, G, Schlossberg, P, Sefrioui, D, Segrestin, M, Seguy, D, Seminur, C, Serin, M, Seryer, A, Sevenet, F, Shekh, N, Silvie, J, Simon, V, Spyckerelle, C, Talbodec, N, Tavernier, N, Tchandeu, H, Techy, A, Thelu, J, Thevenin, A, Thiebault, H, Thomas, J, Thorel, J, Thuillier, C, Tielman, G, Tode, M, Toisin, J, Tonnel, J, Touchais, J, Toumelin, P, Touze, Y, Tranvouez, J, Triplet, C, Triki, N, Turck, D, Uhlen, S, Vaillant, E, Valmage, C, Vanco, D, Vandaele-Bertiaux, N, Vandamme, H, Vanderbecq, E, Vander Eecken, E, Vandermolen, P, Vandevenne, P, Vandeville, L, Vandewalle, A, Vandewalle, C, Vaneslander, P, Vanhoove, J, Vanrenterghem, A, Vanveuren, C, Varlet, P, Vasies, I, Verbiese, G, Verlynde, J, Vernier-Massouille, G, Vermelle, P, Verne, C, Vezilier-Cocq, P, Vigneron, B, Vincendet, M, Viot, J, Voiment, Y, Wacrenier, A, Waeghemaecker, L, Wallez, J, Wantiez, M, Wartel, F, Weber, J, Willocquet, J, Wizla, N, Wolschies, E, Zaharia, O, Zaoui, S, Zalar, A, Zaouri, B, Zellweger, A, Ziade, C, Beaugerie, L, Allez, M, Ruemmele, F, Lamer, A, Roy, M, CHU Lille, Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau (ADEN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Normandie Université (NU), Service d'Hépato-Gastroentérologie [CHU Rouen], Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille], Hôpital Claude Huriez [Lille], CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Universitaire de Reims (CHU Reims), Périnatalité et Risques Toxiques - UMR INERIS_I 1 (PERITOX), Institut National de l'Environnement Industriel et des Risques (INERIS)-Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, CHU Amiens-Picardie, Registre EPIMAD, Normandie Université (NU)-Normandie Université (NU)-CHU Amiens-Picardie-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Department of Colloid Chemistry [Potsdam], Max Planck Institute of Colloids and Interfaces, Max-Planck-Gesellschaft-Max-Planck-Gesellschaft, Groupe de Recherche sur l'alcool et les pharmacodépendances - UMR INSERM_S 1247 (GRAP), and Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Crohn’s disease, inflammatory bowel disease, complication, genetics, prediction, prognosis, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience; Background The identification of patients at high risk of a disabling disease course would be invaluable in guiding initial therapy in Crohn’s disease (CD). Our objective was to evaluate a combination of clinical, serological, and genetic factors to predict complicated disease course in pediatric-onset CD. Methods Data for pediatric-onset CD patients, diagnosed before 17 years of age between 1988 and 2004 and followed more than 5 years, were extracted from the population-based EPIMAD registry. The main outcome was defined by the occurrence of complicated behavior (stricturing or penetrating) and/or intestinal resection within the 5 years following diagnosis. Lasso logistic regression models were used to build a predictive model based on clinical data at diagnosis, serological data (ASCA, pANCA, anti-OmpC, anti-Cbir1, anti-Fla2, anti-Flax), and 369 candidate single nucleotide polymorphisms. Results In total, 156 children with an inflammatory (B1) disease at diagnosis were included. Among them, 35% (n = 54) progressed to a complicated behavior or an intestinal resection within the 5 years following diagnosis. The best predictive model (PREDICT-EPIMAD) included the location at diagnosis, pANCA, and 6 single nucleotide polymorphisms. This model showed good discrimination and good calibration, with an area under the curve of 0.80 after correction for optimism bias (sensitivity, 79%, specificity, 74%, positive predictive value, 61%, negative predictive value, 87%). Decision curve analysis confirmed the clinical utility of the model. Conclusions A combination of clinical, serotypic, and genotypic variables can predict disease progression in this population-based pediatric-onset CD cohort. Independent validation is needed before it can be used in clinical practice.

Published
2023
Full Text
View/download PDF

2. Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn′s Disease: A French Population-Based Study

Author

Duricova, Dana, Sarter, Hélène, Savoye, Guillaume, Leroyer, Ariane, Pariente, Benjamin, Armengol-Debeir, Laura, Bouguen, Guillaume, Ley, Delphine, Turck, Dominique, Templier, Carole, Buche, Sebastien, Peyrin-Biroulet, Laurent, Gower-Rousseau, Corinne, Fumery, Mathurin, Andre, J M, Antonietti, M, Aouakli, A, Armand, A, Aroichane, I, Assi, F, Aubet, J P, Auxenfants, E, Ayafi-Ramelot, F, Bankovski, D, Barbry, B, Bardoux, N, Baron, P, Baudet, A, Bazin, B, Bebahani, A, Becqwort, J P, Benet, V, Benali, H, Benguigui, C, Ben Soussan, E, Bental, A, Berkelmans, I, Bernet, J, Bernou, K, Bernou-Dron, C, Bertot, P, Bertiaux-Vandaële, N, Bertrand, V, Billoud, E, Biron, N, Bismuth, B, Bleuet, M, Blondel, F, Blondin, V, Bohon, P, Boniface, E, Bonnière, P, Bonvarlet, E, Bonvarlet, P, Boruchowicz, A, Bostvironnois, R, Boualit, M, Bouche, B, Boudaillez, C, Bourgeaux, C, Bourgeois, M, Bourguet, A, Bourienne, A, Branche, J, Bray, G, Brazier, F, Breban, P, Brihier, H, Brung-Lefebvre, V, Bulois, P, Burgiere, P, Butel, J, Canva, J Y, Canva-Delcambre, V, Capron, J P, Cardot, F, Carpentier, P, Cartier, E, Cassar, J F, Cassagnou, M, Castex, J F, Catala, P, Cattan, S, Catteau, S, Caujolle, B, Cayron, G, Chandelier, C, Chantre, M, Charles, J, Charneau, T, Chavance-Thelu, M, Chirita, D, Choteau, A, Claerbout, J F, Clergue, P Y, Coevoet, H, Cohen, G, Collet, R, Colombel, J F, Coopman, S, Corvisart, J, Cortot, A, Couttenier, F, Crinquette, J F, Crombe, V, Dadamessi, I, Dapvril, V, Davion, T, Dautreme, S, Debas, J, Degrave, N, Dehont, F, Delatre, C, Delcenserie, R, Delette, O, Delgrange, T, Delhoustal, L, Delmotte, J S, Demmane, S, Deregnaucourt, G, Descombes, P, Desechalliers, J P, Desmet, P, Desreumaux, P, Desseaux, G, Desurmont, P, Devienne, A, Devouge, E, Devred, M, Devroux, A, Dewailly, A, Dharancy, S, Di Fiore, A, Djeddi, D, Djedir, R, Dreher-Duwat, M L, Dubois, R, Dubuque, C, Ducatillon, P, Duclay, J, Ducrocq, B, Ducrot, F, Ducrotté, P, Dufilho, A, Duhamel, C, Dujardin, D, Dumant-Forest, C, Dupas, J L, Dupont, F, Duranton, Y, Duriez, A, El Achkar, K, El Farisi, M, Elie, C, Elie-Legrand, M C, Elkhaki, A, Eoche, M, Evrard, D, Evrard, J P, Fatome, A, Filoche, B, Finet, L, Flahaut, M, Flamme, C, Foissey, D, Fournier, P, Foutrein- Comes, M C, Foutrein, P, Fremond, D, Frere, T, Fumery, M, Gallet, P, Gamblin, C, Ganga-Zandzou, S, Gerard, R, Geslin, G, Gheyssens, Y, Ghossini, N, Ghrib, S, Gilbert, T, Gillet, B, Godard, D, Godard, P, Godchaux, J M, Godchaux, R, Goegebeur, G, Goria, O, Gottrand, F, Gower, P, Grandmaison, B, Groux, M, Guedon, C, Guillard, J F, Guillem, L, Guillemot, F, Guimber, D, Haddouche, B, Hakim, S, Hanon, D, Hautefeuille, V, Heckestweiller, P, Hecquet, G, Hedde, J P, Hellal, H, Henneresse, P E, Heyman, B, Heraud, M, Herve, S, Hochain, P, Houssin-Bailly, L, Houcke, P, Huguenin, B, Iobagiu, S, Ivanovic, A, Iwanicki-Caron, I, Janicki, E, Jarry, M, Jeu, J, Joly, J P, Jonas, C, Katherin, F, Kerleveo, A, Khachfe, A, Kiriakos, A, Kiriakos, J, Klein, O, Kohut, M, Kornhauser, R, Koutsomanis, D, Laberenne, J E, Laffineur, G, Lagarde, M, Lannoy, P, Lapchin, J, Lapprand, M, Laude, D, Leblanc, R, Lecieux, P, Leclerc, N, Le Couteulx, C, Ledent, J, Lefebvre, J, Lefiliatre, P, Legrand, C, Le Grix, A, Lelong, P, Leluyer, B, Lenaerts, C, Lepileur, L, Leplat, A, Lepoutre-Dujardin, E, Leroi, H, Leroy, M Y, Lesage, J P, Lesage, X, Lesage, J, Lescanne-Darchis, I, Lescut, J, Lescut, D, Leurent, B, Levy, P, Lhermie, M, Lion, A, Lisambert, B, Loire, F, Louf, S, Louvet, A, Luciani, M, Lucidarme, D, Lugand, J, Macaigne, O, Maetz, D, Maillard, D, Mancheron, H, Manolache, O, Marks-Brunel, A B, Marti, R, Martin, F, Martin, G, Marzloff, E, Mathurin, P, Mauillon, J, Maunoury, V, Maupas, J L, Mesnard, B, Metayer, P, Methari, L, Meurisse, B, Meurisse, F, Michaud, L, Mirmaran, X, Modaine, P, Monthe, A, Morel, L, Mortier, P E, Moulin, E, Mouterde, O, Mudry, J, Nachury, M, N’Guyen Khac, E, Notteghem, B, Ollevier, V, Ostyn, A, Ouraghi, A, Ouvry, D, Paillot, B, Panien-Claudot, N, Paoletti, C, Papazian, A, Parent, B, Pariente, B, Paris, J C, Patrier, P, Paupart, L, Pauwels, B, Pauwels, M, Petit, R, Piat, M, Piotte, S, Plane, C, Plouvier, B, Pollet, E, Pommelet, P, Pop, D, Pordes, C, Pouchain, G, Prades, P, Prevost, A, Prevost, J C, Quesnel, B, Queuniet, A M, Quinton, J F, Rabache, A, Rabelle, P, Raclot, G, Ratajczyk, S, Rault, D, Razemon, V, Reix, N, Revillon, M, Richez, C, Robinson, P, Rodriguez, J, Roger, J, Roux, J M, Rudelli, A, Saber, A, Savoye, G, Schlosseberg, P, Segrestin, M, Seguy, D, Serin, M, Seryer, A, Sevenet, F, Shekh, N, Silvie, J, Simon, V, Spyckerelle, C, Talbodec, N, Techy, A, Thelu, J L, Thevenin, A, Thiebault, H, Thomas, J, Thorel, J M, Tielman, G, Tode, M, Toisin, J, Tonnel, J, Touchais, J Y, Touze, Y, Tranvouez, J L, Triplet, C, Turck, D, Uhlen, S, Vaillant, E, Valmage, C, Vanco, D, Vandamme, H, Vanderbecq, E, Vander Eecken, E, Vandermolen, P, Vandevenne, P, Vandeville, L, Vandewalle, A, Vandewalle, C, Vaneslander, P, Vanhoove, J P, Vanrenterghem, A, Varlet, P, Vasies, I, Verbiese, G, Vernier-Massouille, G, Vermelle, P, Verne, C, Vezilier-Cocq, P, Vigneron, B, Vincendet, M, Viot, J, Voiment, Y M, Wacrenier, A, Waeghemaecker, L, Wallez, J Y, Wantiez, M, Wartel, F, Weber, J, Willocquet, J L, Wizla, N, Wolschies, E, Zalar, A, Zaouri, B, Zellweger, A, and Ziade, C

Published
2019
Full Text
View/download PDF

3. Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988–2011): A Population-Based Study of French Adolescents

Author

Ghione, Silvia, primary, Sarter, Hélène, additional, Fumery, Mathurin, additional, Armengol-Debeir, Laura, additional, Savoye, Guillaume, additional, Ley, Delphine, additional, Spyckerelle, Claire, additional, Pariente, Benjamin, additional, Peyrin-Biroulet, Laurent, additional, Turck, Dominique, additional, Gower-Rousseau, Corinne, additional, Andre, J M, additional, Antonietti, M, additional, Aouakli, A, additional, Armand, A, additional, Aroichane, I, additional, Assi, F, additional, Aubet, J P, additional, Auxenfants, E, additional, Ayafi-Ramelot, F, additional, Bankovski, D, additional, Barbry, B, additional, Bardoux, N, additional, Baron, P, additional, Baudet, A, additional, Bazin, B, additional, Bebahani, A, additional, Becqwort, J P, additional, Benet, V, additional, Benali, H, additional, Benguigui, C, additional, Soussan, Ben E, additional, Bental, A, additional, Berkelmans, I, additional, Bernet, J, additional, Bernou, K, additional, Bernou-Dron, C, additional, Bertot, P, additional, Bertiaux-Vandaële, N, additional, Bertrand, V, additional, Billoud, E, additional, Biron, N, additional, Bismuth, B, additional, Bleuet, M, additional, Blondel, F, additional, Blondin, V, additional, Bohon, P, additional, Boniface, E, additional, Bonnière, P, additional, Bonvarlet, E, additional, Bonvarlet, P, additional, Boruchowicz, A, additional, Bostvironnois, R, additional, Boualit, M, additional, Bouche, B, additional, Boudaillez, C, additional, Bourgeaux, C, additional, Bourgeois, M, additional, Bourguet, A, additional, Bourienne, A, additional, Branche, J, additional, Bray, G, additional, Brazier, F, additional, Breban, P, additional, Brihier, H, additional, Brung-Lefebvre, V, additional, Bulois, P, additional, Burgiere, P, additional, Butel, J, additional, Canva, J Y, additional, Canva-Delcambre, V, additional, Capron, J P, additional, Cardot, F, additional, Carpentier, P, additional, Cartier, E, additional, Cassar, J F, additional, Cassagnou, M, additional, Castex, J F, additional, Catala, P, additional, Cattan, S, additional, Catteau, S, additional, Caujolle, B, additional, Cayron, G, additional, Chandelier, C, additional, Chantre, M, additional, Charles, J, additional, Charneau, T, additional, Chavance-Thelu, M, additional, Chirita, D, additional, Choteau, A, additional, Claerbout, J F, additional, Clergue, P Y, additional, Coevoet, H, additional, Cohen, G, additional, Collet, R, additional, Colombel, J F, additional, Coopman, S, additional, Corvisart, J, additional, Cortot, A, additional, Couttenier, F, additional, Crinquette, J F, additional, Crombe, V, additional, Dadamessi, I, additional, Dapvril, V, additional, Davion, T, additional, Dautreme, S, additional, Debas, J, additional, Degrave, N, additional, Dehont, F, additional, Delatre, C, additional, Delcenserie, R, additional, Delette, O, additional, Delgrange, T, additional, Delhoustal, L, additional, Delmotte, J S, additional, Demmane, S, additional, Deregnaucourt, G, additional, Descombes, P, additional, Desechalliers, J P, additional, Desmet, P, additional, Desreumaux, P, additional, Desseaux, G, additional, Desurmont, P, additional, Devienne, A, additional, Devouge, E, additional, Devred, M, additional, Devroux, A, additional, Dewailly, A, additional, Dharancy, S, additional, Di Fiore, A, additional, Djeddi, D, additional, Djedir, R, additional, Dreher-Duwat, M L, additional, Dubois, R, additional, Dubuque, C, additional, Ducatillon, P, additional, Duclay, J, additional, Ducrocq, B, additional, Ducrot, F, additional, Ducrotte, P, additional, Dufilho, A, additional, Duhamel, C, additional, Dujardin, D, additional, Dumant-Forest, C, additional, Dupas, J L, additional, Dupont, F, additional, Duranton, Y, additional, Duriez, A, additional, El Achkar, K, additional, El Farisi, M, additional, Elie, C, additional, Elie-Legrand, M C, additional, Elkhaki, A, additional, Eoche, M, additional, Evrard, D, additional, Evrard, J P, additional, Fatome, A, additional, Filoche, B, additional, Finet, L, additional, Flahaut, M, additional, Flamme, C, additional, Foissey, D, additional, Fournier, P, additional, Foutrein-Comes, M C, additional, Foutrein, P, additional, Fremond, D, additional, Frere, T, additional, Fumery, M, additional, Gallet, P, additional, Gamblin, C, additional, Ganga-Zandzou, P S, additional, Gérard, R, additional, Geslin, G, additional, Gheyssens, Y, additional, Ghossini, N, additional, Ghrib, S, additional, Gilbert, T, additional, Gillet, B, additional, Godard, D, additional, Godard, P, additional, Godchaux, J M, additional, Godchaux, R, additional, Goegebeur, G, additional, Goria, O, additional, Gottrand, F, additional, Gower, P, additional, Grandmaison, B, additional, Groux, M, additional, Guedon, C, additional, Guillard, J F, additional, Guillem, L, additional, Guillemot, F, additional, Guimber, D, additional, Haddouche, B, additional, Hakim, S, additional, Hanon, D, additional, Hautefeuille, V, additional, Heckestweiller, P, additional, Hecquet, G, additional, Hedde, J P, additional, Hellal, H, additional, Henneresse, P E, additional, Heyman, B, additional, Heraud, M, additional, Herve, S, additional, Hochain, P, additional, Houssin-Bailly, L, additional, Houcke, P, additional, Huguenin, B, additional, Iobagiu, S, additional, Ivanovic, A, additional, Iwanicki-Caron, I, additional, Janicki, E, additional, Jarry, M, additional, Jeu, J, additional, Joly, J P, additional, Jonas, C, additional, Katherin, F, additional, Kerleveo, A, additional, Khachfe, A, additional, Kiriakos, A, additional, Kiriakos, J, additional, Klein, O, additional, Kohut, M, additional, Kornhauser, R, additional, Koutsomanis, D, additional, Laberenne, J E, additional, Laffineur, G, additional, Lagarde, M, additional, Lannoy, P, additional, Lapchin, J, additional, Lapprand, M, additional, Laude, D, additional, Leblanc, R, additional, Lecieux, P, additional, Leclerc, N, additional, Le Couteulx, C, additional, Ledent, J, additional, Lefebvre, J, additional, Lefiliatre, P, additional, Legrand, C, additional, Le Grix, A, additional, Lelong, P, additional, Leluyer, B, additional, Lenaerts, C, additional, Lepileur, L, additional, Leplat, A, additional, Lepoutre-Dujardin, E, additional, Leroi, H, additional, Leroy, M Y, additional, Lesage, J P, additional, Lesage, X, additional, Lesage, J, additional, Lescanne-Darchis, I, additional, Lescut, J, additional, Lescut, D, additional, Leurent, B, additional, Levy, P, additional, Lhermie, M, additional, Lion, A, additional, Lisambert, B, additional, Loire, F, additional, Louf, S, additional, Louvet, A, additional, Luciani, M, additional, Lucidarme, D, additional, Lugand, J, additional, Macaigne, O, additional, Maetz, D, additional, Maillard, D, additional, Mancheron, H, additional, Manolache, O, additional, Marks-Brunel, A B, additional, Marti, R, additional, Martin, F, additional, Martin, G, additional, Marzloff, E, additional, Mathurin, P, additional, Mauillon, J, additional, Maunoury, V, additional, Maupas, J L, additional, Mesnard, B, additional, Metayer, P, additional, Methari, L, additional, Meurisse, B, additional, Meurisse, F, additional, Michaud, L, additional, Mirmaran, X, additional, Modaine, P, additional, Monthe, A, additional, Morel, L, additional, Mortier, P E, additional, Moulin, E, additional, Mouterde, O, additional, Mudry, J, additional, Nachury, M, additional, Khac, N'Guyen E, additional, Notteghem, B, additional, Ollevier, V, additional, Ostyn, A, additional, Ouraghi, A, additional, Ouvry, D, additional, Paillot, B, additional, Panien-Claudot, N, additional, Paoletti, C, additional, Papazian, A, additional, Parent, B, additional, Pariente, B, additional, Paris, J C, additional, Patrier, P, additional, Paupart, L, additional, Pauwels, B, additional, Pauwels, M, additional, Petit, R, additional, Piat, M, additional, Piotte, S, additional, Plane, C, additional, Plouvier, B, additional, Pollet, E, additional, Pommelet, P, additional, Pop, D, additional, Pordes, C, additional, Pouchain, G, additional, Prades, P, additional, Prevost, A, additional, Prevost, J C, additional, Quesnel, B, additional, Queuniet, A M, additional, Quinton, J F, additional, Rabache, A, additional, Rabelle, P, additional, Raclot, G, additional, Ratajczyk, S, additional, Rault, D, additional, Razemon, V, additional, Reix, N, additional, Revillon, M, additional, Richez, C, additional, Robinson, P, additional, Rodriguez, J, additional, Roger, J, additional, Roux, J M, additional, Rudelli, A, additional, Saber, A, additional, Savoye, G, additional, Schlosseberg, P, additional, Segrestin, M, additional, Seguy, D, additional, Serin, M, additional, Seryer, A, additional, Sevenet, F, additional, Shekh, N, additional, Silvie, J, additional, Simon, V, additional, Spyckerelle, C, additional, Talbodec, N, additional, Techy, A, additional, Thelu, J L, additional, Thevenin, A, additional, Thiebault, H, additional, Thomas, J, additional, Thorel, J M, additional, Tielman, G, additional, Tode, M, additional, Toisin, J, additional, Tonnel, J, additional, Touchais, J Y, additional, Touze, Y, additional, Tranvouez, J L, additional, Triplet, C, additional, Turck, D, additional, Uhlen, S, additional, Vaillant, E, additional, Valmage, C, additional, Vanco, D, additional, Vandamme, H, additional, Vanderbecq, E, additional, Eecken, Vander E, additional, Vandermolen, P, additional, Vandevenne, P, additional, Vandeville, L, additional, Vandewalle, A, additional, Vandewalle, C, additional, Vaneslander, P, additional, Vanhoove, J P, additional, Vanrenterghem, A, additional, Varlet, P, additional, Vasies, I, additional, Verbiese, G, additional, Vernier-Massouille, G, additional, Vermelle, P, additional, Verne, C, additional, Vezilier-Cocq, P, additional, Vigneron, B, additional, Vincendet, M, additional, Viot, J, additional, Voiment, Y M, additional, Wacrenier, A, additional, Waeghemaecker, L, additional, Wallez, J Y, additional, Wantiez, M, additional, Wartel, F, additional, Weber, J, additional, Willocquet, J L, additional, Wizla, N, additional, Wolschies, E, additional, Zalar, A, additional, Zaouri, B, additional, Zellweger, A, additional, and Ziade, C, additional

Published
2018
Full Text
View/download PDF

7. Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.

Author

Hochain P, Berkelmans I, Czernichow P, Duhamel C, Tranvouez JL, Lerebours E, and Colin R

Subjects
Adrenal Cortex Hormones administration & dosage, Adrenal Cortex Hormones adverse effects, Aged, Aged, 80 and over, Alcoholism complications, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Aspirin administration & dosage, Aspirin adverse effects, Case-Control Studies, Duodenal Ulcer chemically induced, Duodenum drug effects, Female, Gastric Mucosa drug effects, Humans, Male, Middle Aged, Nutritional Status, Peptic Ulcer complications, Posture, Risk Factors, Smoking adverse effects, Stomach Ulcer chemically induced, Stress, Physiological complications, Weight Loss, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Gastrointestinal Hemorrhage chemically induced
Abstract

Objective: To identify risk factors for gastrointestinal bleeding (GIB) among users of non-aspirin, non-steroidal anti-inflammatory drugs (NANSAIDs)., Design: Case-control study., Participants: A total of 120 patients aged over 60 years and using NANSAIDs were hospitalized between January 1988 and September 1992 for GIB related to erosions or ulceration of the gastroduodenal mucosa. A group of 100 general practitioners selected two controls matched for age and sex, receiving NANSAIDs and without GIB, for each patient., Methods: The same questionnaire was used to interview patients and controls about their medical history, use of NANSAIDs and other drugs, alcohol and tobacco use, recent stress and nutritional status., Results: The adjusted odds ratios (OR) for the risk factors related to the pattern of NANSAID use were 3.39 [95% confidence interval (CI) 1.77-6.47] when the intake of NANSAIDs was followed by decubitus, 3.00 (95% CI 1.54-5.85) when NANSAIDs were taken before a meal, 6.05 (95% CI 2.10 17.43) with a high dose of NANSAIDs, 5.87 (95% CI 2.00-17.25) with recent NANSAID use, 3.35 (95% CI 1.47-7.64) with NANSAIDs associated with aspirin use, 3.46 (95% CI 1.15-10.36) with more than one NANSAID, and 10.70 (95% CI 1.06-108.07) when NANSAIDs were associated with corticosteroids. The patient-related risk factors and their OR were 9.94 (95% CI 3.29-24.28) for irregular food intake, 3.94 (95% CI 1.45-10.69) for previous peptic ulcer, 3.71 (95% CI 1.26-10.89) for recent weight loss, 4.44 (95% CI 1.48-13.30) for heavy alcohol abuse, 2.92 (95% CI 1.36-6.26) for recent stress and 5.26 (95% CI 1.19-23.33) for a past history of GIB., Conclusion: This study identified a group at 'high risk' for GIB which would benefit from the development of a prophylactic therapy.

Published
1995

9. [Gaucher's disease type 1: apropos of 17 cases].

Author

Belmatoug N, de Bandt M, Oksenhendler E, Bergmann JF, Dupond JL, Rispal P, Lasseur C, Yeni P, Tranvouez JL, and Carbon C

Subjects
Adult, Humans, Middle Aged, Gaucher Disease blood, Gaucher Disease complications, Gaucher Disease diagnosis
Abstract

Gaucher's disease is characterized by accumulation of glucocerebroside (caused by an autosomally inherited deficiency of glucocerebrosidase) in the cells of the reticuloendothelial system. We report the clinical, laboratory, radiologic features of 17 patients with type 1 Gaucher's disease.

Published
1993
Full Text
View/download PDF

10. Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency.

Author

Lacroix C, Tranvouez JL, Phan Hoang T, Duwoos H, and Lafont O

Subjects
Adult, Chromatography, High Pressure Liquid, Female, Half-Life, Humans, Liver Function Tests, Male, Pyrazinamide analogs & derivatives, Pyrazinamide blood, Pyrazinamide metabolism, Liver Cirrhosis metabolism, Pyrazinamide pharmacokinetics
Abstract

The pharmacokinetics of pyrazinamide (Pirilène) and its metabolites are evaluated in ten subjects with hepatic insufficiency, after an oral dose of 19.3 +/- 0.6 mg.kg-1 and the results are compared to those of a group of nine healthy subjects (control group). The results exhibit a marked reduction of the pyrazinamide total clearance (0.48 vs 0.84 ml.min-1.kg-1) and an increase in half-life from 9.19 h to 15.07 h in the patients group. The area under the curve of pyrazinoic acid (the main metabolite) is increased from 97 to 280 mg.h.l-1 with a half-life twice as much as that of the control group. The hepatic insufficiency entails a marked reduction of the common posology as well as a closer survey of the biologic hepatic parameters and of uric acid the renal elimination of which is inhibited by pyrazinoic acid.

Published
1990

11. [Agenesis of the right lobe of the liver. Apropos of a case].

Author

Collay R, Anne F, de Vanssay de Blavous P, Gazel de la Contrie D, Weinstein D, Gaussin G, Tranvouez JL, and Dodart T

Subjects
Humans, Liver diagnostic imaging, Male, Middle Aged, Tomography, X-Ray Computed, Ultrasonography, Liver abnormalities
Abstract

The authors describe a recent case of agenesis of the right lobe of the liver. Such cases are rare and can be diagnosed with state of the art imaging modalities, ultrasound and computed tomography, which permit early diagnosis and help avoid liver complications of cirrhosis, cholangiocarcinoma and hepatoma. This type of congenital anomaly can be associated with biliary tract disease, portal hypertension or other congenital anomalies.

Published
1990

12. Somatostatin in peptic ulcer bleeding--results of a double-blind controlled trial.

Author

Galmiche JP, Cassigneul J, Faivre J, Tranvouez JL, Ouvry D, Colin R, Pascal JP, and Klepping C

Subjects
Age Factors, Aged, Cimetidine therapeutic use, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Male, Middle Aged, Somatostatin adverse effects, Peptic Ulcer Hemorrhage drug therapy, Somatostatin therapeutic use
Abstract

The aim of this work was to assess the usefulness of somatostatin in acute peptic ulcer bleeding. Sixty-four patients with endoscopic evidence of duodenal ulcer bleeding completed a double-blind trial to compare the effectiveness of somatostain (6 mg i.v. per day) with that of placebo; incidence of treatment failure (i.e., rebleeding or persistent haemorrhage) was not different in the somatostatin and in the placebo groups (respectively 24% and 23%). Because the efficacy of cimetidine had previously been demonstrated in gastric ulcer bleeding, somatostatin was tested against cimetidine (1.6 g per day) in 50 patients with gastric ulcer haemorrhage. The treatment failed to control bleeding in 15% of somatostatin and in 17% of cimetidine treated subjects (n.s.). Both treatments were well tolerated and blood requirements were not different in the trial groups. These results show that the efficacy of somatostain in peptic ulcer bleeding is not different from placebo in duodenal ulcers and not different from cimetidine in gastric ulcers.

Published
1983

13. [Hereditary visceral myopathy: an entity in idiopathic intestinal pseudo-obstruction].

Author

Ducastelle T, Tranvouez JL, Lerebours E, Hemet J, Muller JM, Denis P, Hecketsweiler P, and Colin R

Subjects
Adolescent, Colon pathology, Colon ultrastructure, Female, Gastrointestinal Motility, Humans, Ileum pathology, Ileum ultrastructure, Intestinal Pseudo-Obstruction physiopathology, Jejunum pathology, Jejunum ultrastructure, Microscopy, Electron, Muscular Diseases pathology, Muscular Diseases physiopathology, Urodynamics, Intestinal Obstruction pathology, Intestinal Pseudo-Obstruction pathology, Muscle, Smooth pathology, Muscular Diseases genetics
Abstract

A 17 year-old girl with chronic idiopathic intestinal pseudo-obstruction is reported. Abnormalities of smooth intestinal muscle were shown on light and electron microscopic studies of the excised small intestine and led to the diagnosis of visceral myopathy based on the following features: vacuolar degeneration of intestinal smooth muscle cells with replacement by fibrous preferential involvement of the external longitudinal muscle layer normal myenteric plexus. For the first time similar ultrastructural changes were found on histological study of the colon. Manometric studies revealed a diffuse disease involving the esophagus, small bowel, and bladder. Anorectal abnormalities, never described before, were reported. Family involvement was shown by abnormal esophageal and anorectal manometries in the patient's brother and by paternal history of fatal small intestine occlusion without mechanical obstruction. The prognosis of severe forms of visceral myopathy is generally poor because of the inefficiency of drugs. In this case, after a long period of parenteral nutrition with maintenance of a good nutritional status, a terminal ileostomy (with a special procedure to avoid evagination) associated with a second stage total colectomy allowed to stop parenteral nutrition.

Published
1986

14. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation.

Author

Tranvouez JL, Lerebours E, Chretien P, Fouin-Fortunet H, and Colin R

Subjects
Adult, Blood Proteins analysis, Energy Intake, Energy Metabolism, Female, Humans, Kinetics, Male, Metabolic Clearance Rate, Middle Aged, Nutrition Disorders classification, Nutrition Disorders therapy, Protein-Energy Malnutrition metabolism, Antipyrine metabolism, Liver enzymology, Mixed Function Oxygenases metabolism, Nutrition Disorders metabolism
Abstract

The present study of hepatic mixed function oxidase activity was carried out by determining antipyrine clearance in 49 patients presenting with energy malnutrition (group E, n = 26) or global protein-calorie malnutrition (group P, n = 23). A control group (group C, n = 25) was composed of subjects with good nutritional status. The metabolic clearance rate and weight-corrected clearance in group P were significantly lower than those in groups E and C. The weight clearances in the latter two groups were not significantly different, suggesting that mixed function oxidase activity decreases only in protein-calorie malnutrition. Antipyrine clearance was studied again in 27 patients after nutritional rehabilitation with artificial nutrition for 31 +/- 4 days (means +/- SEM). Concomitant with an improvement in nutritional state, clearances tended towards normal values in group P (n = 17) and were not significantly modified in group E (n = 10). It is thus important to take the type of malnutrition into account in pharmacological studies of malnourished humans in order to correctly adapt therapeutic doses.

Published
1985
Full Text
View/download PDF

15. [Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients].

Author

Queuniet AM, Czernichow P, Lerebours E, Ducrotte P, Tranvouez JL, and Colin R

Subjects
Adult, Aged, Clinical Trials as Topic, Esophageal and Gastric Varices complications, Follow-Up Studies, Humans, Hypertension, Portal complications, Middle Aged, Recurrence, Rupture, Spontaneous, Gastrointestinal Hemorrhage prevention & control, Liver Cirrhosis complications, Propranolol therapeutic use
Abstract

The aim of this study was to assess, by a pragmatic controlled trial, the value of propranolol in the prevention of recurrent bleeding in patients with cirrhosis. From January 1982 to December 1984, 368 cirrhotic patients were admitted for bleeding episode due to portal hypertension. Ninety-nine patients were included in the trial 24 h after cessation of bleeding (5 days on the average after hospital admission) and were randomly assigned to 2 groups: 51 patients receiving propranolol at doses that reduced the resting heart rate by 25 p. 100 and 48 receiving neither treatment nor placebo. Ninety-one per cent presented a rupture of varices, and 9 p. 100 acute gastric erosions: 94 p. 100 had an alcoholic cirrhosis. The distribution according to Child Turcotte's classification was grade A: 45.5 p. 100, B: 45.5 p. 100, C: 100 p. 100. The two groups were not significantly different excepted for previous bleeding episodes. The cumulative percentages of recurrent bleeding were not significantly different: between the treated and untreated groups (60 p. 100 vs. 68 p. 100 at 18 months); between the compliant patients (n = 39) and untreated and not compliant patients altogether; between the treated and untreated patients of Child's grade A on the one hand, and patients grades B and C on the other hand. The curves of cumulative survival were not significantly different between treated and untreated patients (66 p. 100 vs. 78 p. 100 at 18 months).(ABSTRACT TRUNCATED AT 250 WORDS)

Published
1987

16. [Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].

Author

Galmiche JP, Tranvouez JL, Denis P, N'Djitoyap C, Guillard JF, Lehur PA, and Colin R

Subjects
Adult, Aged, Cimetidine, Drug Resistance, Female, Gastric Acid metabolism, Humans, Hydrogen-Ion Concentration, Male, Middle Aged, Monitoring, Physiologic, Ranitidine administration & dosage, Time Factors, Duodenal Ulcer drug therapy, Gastric Acidity Determination, Ranitidine therapeutic use
Abstract

The present work was conducted in patients with severe cimetidine-resistant duodenal ulcer, in order to correlate the response (i. e. healing or no healing of the ulcer) to ranitidine therapy and the results of 24 h gastric pH monitoring performed under therapeutic conditions. Twenty patients who fulfilled the criteria of cimetidine resistance (i. e. with an ulcer not healed after a treatment with cimetidine given at a dose of at least 1 g/d for at least 6 weeks) received 150 mg ranitidine twice daily for 6 weeks and were then controlled endoscopically; ulcer was healed in 8 cases, not healed in 12 cases. Nocturnal gastric acid inhibition was significantly greater in patients who responded to ranitidine than in those whose ulcer did not heal. During daytime the gastric pH profiles were not different between these two groups. Nocturnal pH score was also calculated in each patient by reference to the mean inhibitory effect observed in 8 normal subjects in whom gastric pH was monitored in the same therapeutic conditions. In 7 patients the nocturnal pH score was greater than 10; none of these patients was healed after 6 weeks ranitidine treatment. Among the 13 patients with a pH score lower than 10, 8 had an ulcer healed at the end of the ranitidine course. In 5 cases gastric pH monitoring was repeated after continuation of the ranitidine treatment; healing of ulcer was observed in 4 cases, always associated with a nocturnal pH score lower than 10 (in 2 cases after increasing the dosage of ranitidine).(ABSTRACT TRUNCATED AT 250 WORDS)

Published
1985

Catalog

Books, media, physical & digital resources
See catalog results